Advertisement NEUROFIT - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

NEUROFIT

Preclinical Research

Logo
LATEST PRESS RELEASES
February 15, 2010

Animal Model of Relapsing-Remitting Multiple Sclerosis: Relapsing-Remitting Experimental Autoimmune Encephalomyelitis in the Rat

Neurofit is pleased to provide the model of Relapsing-Remitting Experimental Autoimmune Encephalomyelitis (RR-EAE) in the rat.
pharmacuetical business review
January 15, 2010

New In-Vivo Model of Panic Anxiety Available at Neurofit

Neurofit is pleased to provide the model of Cholecystokinin tetrapeptide (CCK-4) –induced panic anxiety to their potential customers.
pharmacuetical business review


LATEST VIDEOS

NEUROFIT

NEUROFIT is a CRO (Contract Research Organisation) specialised in the evaluation of treatments for central (CNS) and peripheral nervous system (PNS) disorders, autoimmune diseases and for Oncology.

Drug screening

NEUROFIT is located near Strasbourg (France) and is part of the Alsace BioValley Network. NEUROFIT offers a long list of validated methods and disease models for drug screening and provides customers with high quality research data and reports. We have an extensive Quality Assurance Program, covering reception of samples through final reporting.

Contact NEUROFIT

Boulevard S颡stien Brant
Bioparc – Parc d’Innovation
67400 Illkirch
France
Tel: +33 (0)3 88 65 16 06
Fax: +33 (0)3 88 65 16 22
Email: neurofit@neurofit.com
Website: www.neurofit.com

Models and Assays

In Vitro Neurofit offers a large range of models and assays for evaluating neurotoxicity, neuroprotection or neurotrophic activity of new test compounds. We can also develop custom protocols to determine mechanism of action, or define therapeutic indication of new drug candidates. Rodent Primary Culture: Cortical, hippocampal, mesencephalon neurons Spinal cord motor neurons Sensory neurons (dissociated…

Neurofit Programmes

Compound Neurofit designs screening programmes for specific target indications. According to your target indications we can establish a screening programme for your drug project. In-house expertise allows us to assist you in most central and peripheral nervous system disorders. Phenomouse The Phenomouse programme consists of phenotyping mutant mice by behavioural, histological and biochemical tests. A…

Research Collaboration

Work with Neurofit as if it was part of your own organisation: Under a Master Services Agreement a programme can be established where you work directly with the scientist responsible for the testing. This will allow you to rapidly obtain access to already validated screening methods and to draw on our in-house expertise. Data reporting,…
Quick Contact NEUROFIT
Quick Contact NEUROFIT


Quick Contact NEUROFIT
Quick Contact NEUROFIT
Quick Contact NEUROFIT


Contact NEUROFIT

Optional Data

Almost there, complete this form and hit the submit button to complete your registration.

Confirmation

Finally, complete a quick security check and confirm terms and conditions:

Quick Contact NEUROFIT